A top executive at Advanced Micro Devices Inc. AMD made a sizable open market purchase in the stock this week, signaling confidence in the chipmaker's prospects, amid strengthening fundamentals and easing geopolitical pressures.

FirstFarms' Q1 result was not as originally expected ...

Frankfurt, 23 May 2025 - Swedish regulated crypto asset manager Virtune brings its flagship Virtune XRP ETP to Germany's premier trading venue Deutsche Börse Xetra, extending its regulated digital asset offerings to Europe's largest economy.With strong traction and consistent inflows across the ...

CEO of JPMorgan Chase JPM, Jamie Dimon, has reportedly made a commitment to intensify the bank's association with Chinese capital markets. What Happened: Dimon's pledge follows a meeting with high-ranking Chinese officials, including Beijing's chief trade negotiator, He Lifeng.

General Motors Co.'s GM luxury subsidiary, Cadillac, is experiencing increased adoption of its EVs among Tesla Inc. TSLA owners. What Happened: Cadillac says that 75% of the customers buying Cadillacs are switching over from other manufacturers, with 10% of those being Tesla owners, Business ...

Is Tether MiCA compliant? The EU's new Markets in Crypto-Assets regulation, better known as MiCA, is the first major attempt by a global economic power to create clear, region-wide rules for the crypto space, and stablecoins are a big focus.MiCA mandates best practices.

While investors are assessing the potential impacts of the "One Big Beautiful Bill Act," this expert is urging investors to look beyond and consider a more potent market mover - U.S. tariff policy.

Resolutions of the Annual General Meeting of Shareholders of AS Ekspress Grupp held on 23 May ...

Frontline plc FRO will release its first-quarter earnings results before the opening bell on Friday, May 23. Analysts expect the Limassol, Cyprus-based company to report quarterly earnings at 23 cents per share, down from 62 cents per share in the year-ago period.

Daix ( France ) , New York City ( New York, United States ) , May 23, 2025 - Inventiva ( Euronext Paris and Nasdaq: IVA ) ( the "Company" ) , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated ...